BPC157 + TB500

Multi-Buy Savings — Add 2+ products to save 10% automatically. Add 3+ to save 15%. Applied at checkout.

BPC-157 + TB-500 is a research peptide combination pairing two of the most studied tissue-repair compounds in preclinical science. BPC-157 (CAS 137525-51-0) is a gastric-derived pentadecapeptide studied for angiogenesis, GI mucosal protection, and musculoskeletal healing. TB-500 (the active actin-sequestering fragment of Thymosin β4; parent compound CAS 107761-42-2) is studied for cellular migration, connective tissue repair, and cardiac regeneration pathways.

The combination is frequently investigated in preclinical recovery research due to their complementary and potentially synergistic mechanisms: BPC-157 primarily through NO-system modulation and growth factor signalling, and TB-500 through actin sequestration and LKKTETQ-domain-mediated cell migration. Available in 10 mg and 20 mg formats.

BPC-157 CAS: 137525-51-0  ·  TB-500 (Thymosin β4) CAS: 107761-42-2  ·  Purity: ≥99% HPLC (each component)  ·  Format: Lyophilised powder blend  ·  Storage: −20 °C

Research Areas: Synergistic tissue repair · Angiogenesis · Musculoskeletal recovery · GI mucosal biology · Cardiac regeneration models · Cellular migration

Research Literature:
• BPC-157: wound healing and angiogenesis in vivo (PMID 25995620)
• Thymosin beta4 accelerates wound healing (PMID 10469335)
• Actin binding site of thymosin beta4 promotes angiogenesis (PMID 14500546)

Research Use Only. Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.